T3	Procedure 215 224	treatment
E3	Procedure:T3 
T5	Or 411 413	or
E5	Or:T5 Arg:T47 Arg2:T48
T6	Eq-Comparison 422 455	greater than or equal to 19 years
E6	Eq-Comparison:T6 Operator:T49 Value:T50 Temporal-Unit:T51
T7	Condition 523 531	diabetes
E7	Condition:T7 Name:T52
T8	And 532 535	and
E8	And:T8 Arg:E7 Arg2:E47
T9	Drug 549 562	basal insulin
E9	Drug:T9 Name:T53 Temporality:E10 Duration:E11
T10	Eq-Comparison 568 604	1-3 bolus insulin injections per day
E10	Eq-Comparison:T10 Value:T54 Value:T55 Operator:T56 Per:T57
T11	Eq-Comparison 609 626	at least 24 weeks
E11	Eq-Comparison:T11 Operator:T58 Value:T59 Temporal-Unit:T60
T12	Temporal-Connection 627 635	prior to
E12	Temporal-Connection:T12 Arg:E9
A1	Temporal-Connection-Type-Value E12 before
T13	Observation 683 688	HbA1c
E13	Observation:T13 Name:T61 Temporality:E14
T14	Eq-Comparison 695 725	less than or equal to 12 weeks
E14	Eq-Comparison:T14 Value:T63 Temporal-Unit:T64 Operator:T62
T15	Temporal-Connection 726 734	prior to
E15	Temporal-Connection:T15 Arg:E14 Arg2:E16
A2	Temporal-Connection-Type-Value E15 before
T16	Eq-Comparison 735 745	initiation
E16	Eq-Comparison:T16 Temporal-Recency:T82
T17	Drug 749 760	NovoMix® 30
E17	Drug:T17 Name:T83
T18	Eq-Comparison 796 804	Previous
E18	Eq-Comparison:T18 Temporal-Period:T66
T19	Study 827 832	study
E19	Study:T19 Temporality:E18
T20	Condition 911 928	Mental incapacity
E20	Condition:T20 Name:T67
T21	Modifier 930 943	unwillingness
E21	Modifier:T21 
T22	Or 944 946	or
E22	Or:T22 Arg:E21 Arg2:E23
T23	Condition 947 964	language barriers
E23	Condition:T23 Name:T68
T24	Study 1040 1054	clinical trial
E24	Study:T24 
T25	Study 1087 1102	investigational
E25	Study:T25 Study-Of:E27
T27	Drug 1103 1120	medicinal product
E27	Drug:T27 Temporality:E28
T28	Eq-Comparison 1121 1136	within 24 weeks
E28	Eq-Comparison:T28 Operator:T69 Value:T70 Temporal-Unit:T71
T29	Temporal-Connection 1137 1145	prior to
E29	Temporal-Connection:T29 Arg:E28 Arg2:E30
A3	Temporal-Connection-Type-Value E29 before
T30	Eq-Comparison 1146 1156	initiation
E30	Eq-Comparison:T30 Temporal-Recency:T72
T31	Drug 1160 1171	NovoMix® 30
E31	Drug:T31 Name:T73
T33	Procedure 1172 1181	treatment
E33	Procedure:T33 Temporality:E30
T37	Condition 1246 1262	Hypersensitivity
E37	Condition:T37 Name:T75
T38	Drug 1266 1277	NovoMix® 30
E38	Drug:T38 Name:T76
T40	Or 1278 1280	or
E40	Or:T40 Arg:E38 Arg2:E32
T42	Condition 1311 1320	Pregnancy
E42	Condition:T42 Name:T78
T43	Or 1321 1323	or
E43	Or:T43 Arg:E42 Arg2:E44
T44	Assertion 1324 1333	intention
E44	Assertion:T44 Asserted:E45
A4	Assertion-Type-Value E44 intention
T45	Condition 1346 1354	pregnant
E45	Condition:T45 Name:T79
T47	Life-Stage-And-Gender 406 410	Male
A5	Life-Stage-And-Gender-Type T47 male
T48	Life-Stage-And-Gender 414 420	female
A6	Life-Stage-And-Gender-Type T48 female
T49	Eq-Operator 422 443	greater than or equal
A7	Eq-Operator-Value T49 GTEQ
T50	Eq-Value 447 449	19
T51	Eq-Temporal-Unit 450 455	years
A8	Eq-Temporal-Unit-Value T51 year
T52	Condition-Name 523 531	diabetes
T53	Drug-Name 549 562	basal insulin
T54	Eq-Value 568 569	1
T55	Eq-Value 570 571	3
T57	Eq-Temporal-Unit 601 604	day
A9	Eq-Temporal-Unit-Value T57 day
T58	Eq-Operator 609 617	at least
A10	Eq-Operator-Value T58 GTEQ
T59	Eq-Value 618 620	24
T60	Eq-Temporal-Unit 621 626	weeks
A11	Eq-Temporal-Unit-Value T60 week
T61	Observation-Name 683 688	HbA1c
A12	Observation-Type-Value T61 lab
T62	Eq-Operator 695 713	less than or equal
A13	Eq-Operator-Value T62 LTEQ
T63	Eq-Value 717 719	12
T64	Eq-Temporal-Unit 720 725	weeks
A14	Eq-Temporal-Unit-Value T64 week
T66	Eq-Temporal-Period 796 804	Previous
A15	Eq-Temporal-Period-Value T66 past
T67	Condition-Name 911 928	Mental incapacity
T68	Condition-Name 947 964	language barriers
T69	Eq-Operator 1121 1127	within
A16	Eq-Operator-Value T69 LTEQ
T70	Eq-Value 1128 1130	24
T71	Eq-Temporal-Unit 1131 1136	weeks
A17	Eq-Temporal-Unit-Value T71 week
T72	Eq-Temporal-Recency 1146 1156	initiation
A18	Eq-Temporal-Recency-Value T72 first-time
T73	Drug-Name 1160 1171	NovoMix® 30
T75	Condition-Name 1246 1262	Hypersensitivity
T76	Drug-Name 1266 1277	NovoMix® 30
T78	Condition-Name 1311 1320	Pregnancy
T79	Condition-Name 1346 1354	pregnant
T1	Drug 253 264	NovoMix® 30
E1	Drug:T1 Name:T2
T2	Drug-Name 253 264	NovoMix® 30
R1	Using Arg1:E3 Arg2:E1	
T46	Assertion 194 214	decision to initiate
E2	Assertion:T46 Asserted:E3
A19	Assertion-Type-Value E2 hypothetical
T4	Age 450 455	years
E4	Age:T4 Eq-Comparison:E6
T80	Modifier 516 522	type 2
E46	Modifier:T80 Modifies:T52
T81	Procedure 536 543	treated
E47	Procedure:T81 
R2	Using Arg1:E47 Arg2:E9	
T56	Eq-Operator 569 570	-
A20	Eq-Operator-Value T56 BETWEEN
T82	Eq-Temporal-Recency 735 745	initiation
A21	Eq-Temporal-Recency-Value T82 first-time
T83	Drug-Name 749 760	NovoMix® 30
T65	Procedure 761 770	treatment
E48	Procedure:T65 Temporality:E16
R3	Using Arg1:E48 Arg2:E17	
T26	Or 1070 1072	or
E26	Or:T26 Arg:E24 Arg2:E25
R4	Using Arg1:E33 Arg2:E31	
R5	Caused-By Arg1:E37 Arg2:E38	
T32	Coreference 1295 1305	excipients
E32	Coreference:T32 Refers-To:E38
R6	Caused-By Arg1:E37 Arg2:E32	
